Introduction {#S1}
============

*Vibrio cholerae*, a Gram-negative bacterium from the family Vibrionaceae, causes cholera, a self-limiting acute diarrheal disease ([@B59]). This contagious disease spreads primarily through the fecal--oral route and by consumption of contaminated food and water ([@B43]; [@B11]). *V. cholerae* is classified into more than 200 serogroups on the basis of their lipopolysaccharide antigens, yet only two serogroups, O1 and O139, are associated with epidemic outbreaks of cholera ([@B55]). It is estimated that about 2.86 million people are affected by cholera in endemic countries, resulting in 95,000 deaths annually ([@B3]).

Antibiotic therapy is crucial for the treatment of cholera, as it abates the period of diarrhea, the amount of rehydration fluids, and the density of vibrios excreted in the stools ([@B56]). Over the years, the rapid emergence of extensive drug-resistant (XDR) and multidrug-resistant (MDR) *V. cholerae* strains possess a great public health threat, owing to their association with treatment failure and potential dissemination of resistance among other pathogens through mobile genetic elements (MGEs) ([@B10]; [@B11]; [@B53]; [@B15]). The above caveats compel the need for developing novel strategies to thwart *V. cholerae* infection. Numerous studies have focused on developing compounds that target other fitness tactics of bacteria instead of developing newer antibiotics ([@B19], [@B20]).

*V. cholerae* demonstrates extraordinary fitness by coordinated group behavior in expressing virulence factors through quorum sensing (QS) pathways ([@B32]; [@B16]). There are two major parallel QS systems in *V. cholerae* comprising cholera autoinducer-1 (CAI-1), autoinducer 2 (AI-2), and their corresponding cognate inner membrane receptors (CqsS and LuxP/Q) ([@B31]; [@B42]). These individual receptors converge the information to a global response regulator, LuxO, in response to the low and high concentrations of their respective signals. Under low signal strength (LSS), the receptors function as kinases and phosphorylate LuxO, which activates the transcription of quorum regulatory RNAs (Qrrl-4) and controls the translation of two master regulators, AphA and HapR. The *qrr*1-4 small RNAs upregulate the expression of AphA and concurrently repress the expression of HapR ([@B42]). In turn, AphA regulates the expression of biofilm activator (VpsT), toxin-coregulated pilus (TCP), and cholera toxin (CTX), commencing the process of adhesion and production of CTX in humans ([@B30]; [@B57]; [@B42]). These processes are key to the colonization of this bacterium in the intestine and form microcolonies. By contrast, under high signal strength (HSS), the receptors function as phosphatases, leading to dephosphorylation and inactivation of LuxO. This results in the downregulation of virulence and biofilm formation by the expression of hemagglutinin/protease A (HapA). HapA expression facilitates the dissemination of bacteria from the intestinal cells. Thus, LSS promotes infection, whereas HSS promotes bacterial detachment from the intestinal cells, resulting in dissemination ([@B60]; [@B16]).

Anti-virulence therapy using synthetic and natural molecules that interfere with QS pathways in pathogens has been explored extensively. These molecules function either as an inhibitor or an agonist of the factors involved in QS signaling, affecting their biosynthesis, detection, signal transduction, and even as enzymes that inactivated the QS signal molecules ([@B13]). Such QS molecules that occur naturally have been sourced from various plants, microorganisms, and higher organisms from a wide range of terrestrial and marine ecosystems. Among microorganisms, the phylum Actinobacteria has been a prodigious source of anti-virulence agents, providing a range of chemicals that interfere with the QS system of various human pathogens ([@B45]). In this work, we isolated and screened 42 rare marine Actinobacteria (RMA) from mangrove soil against rugose *V. cholerae* HYR14 biofilm and virulence. The organic solvent of RMA displaying a significant anti-biofilm activity was also analyzed for its potential to inhibit virulence mechanism through gene expression studies. Finally, the potential interaction of the active principles identified in the organic extract of RMA with the *V. cholerae* global response regulators LuxO and HapR was analyzed through *in silico* docking studies.

Materials and Methods {#S2}
=====================

Target Bacterial Strains and Culture Conditions {#S2.SS1}
-----------------------------------------------

*Vibrio cholerae* biofilm-forming rugose strain, HYR14 obtained from NICED, India, was used throughout this study ([@B10]). The strain was cultured in thiosulfate--citrate--bile salts--sucrose (TCBS) agar to confirm cell viability and propagated under standard growth conditions in Luria--Bertani (LB) broth at 37°C. An inoculum size of 0.2 (OD~595~) ≈ 10^5^ cells were used for all the experiments ([@B19]).

Soil Sampling From Mangrove Ecosystem {#S2.SS2}
-------------------------------------

Mangrove soil was sampled from Muthupet Mangrove Reserve, Tamil Nadu, India ([Supplementary Table S1](#TS1){ref-type="supplementary-material"}). Soil samples were collected using sterile containers from a site that was 20 m away from the shore and with 20 m depth. The samples were transported to the laboratory under cooling conditions and stored at 4°C in a dry condition prior to examination ([@B22]). The physio-chemical parameters such as salinity and temperature were measured using a handheld refractometer (Erma, Japan) during sample collection. The pH of the samples was determined using Eutech pH meter (Oakton, United States).

Pretreatment of Mangrove Soil and Selective Isolation of Rare Marine Actinobacteria {#S2.SS3}
-----------------------------------------------------------------------------------

The soil was sieved through a large mesh to eliminate organic particles and was homogenized using a mortar and pestle. About 1 g of the homogenized samples was pretreated by 120°C for 60 min (dry heat) ([@B38]) and by 1.5% of phenol for 30 min at 30°C ([@B38]) and through moist heating with sterilized mangrove water at 50°C for 15 min ([@B50]). The pretreated soil samples were then serially diluted \[1:10 (v/v) ratio\] with sterile saline solution, and about 100 μl was spread plated on various isolation media. For selective isolation of RMA, International Streptomyces Project medium (ISP1 to ISP7) ([@B48]), actinomycetes isolation agar, starch casein agar, and humic acid--vitamin agar ([@B18]) (HiMedia Laboratories, Mumbai, India) ([Supplementary Table S2](#TS1){ref-type="supplementary-material"}) supplemented with the filter-sterilized cycloheximide (40 μg/ml) and nalidixic acid (40 μg/ml) were used. The inoculated Petri plates were then incubated at 28°C for 4--6 weeks and regularly checked for the growth of actinomycetes-like colonies. Single discrete actinomycetes-like colonies grown on spread plated isolation media were re-subcultured on to ISP4 and actinomycetes isolation agar and further incubated at 28°C for the isolation of pure colonies ([@B48]). Collection of pure colonies of the RMA isolates was stored at 4°C on ISP4 agar slants and also as lyophilized cultures for short-term and long-term storages, respectively.

Cultural, Morphological, and Biochemical Characterization of Rare Marine Actinobacteria Isolates {#S2.SS4}
------------------------------------------------------------------------------------------------

The RMA isolates collected from various isolation media were subjected to morphological characterization and biochemical analysis ([@B39]; [@B48]). Light microscopy was used to observe the morphologies of Actinobacteria isolates including the arrangement of mycelium and formation of spores by Gram's staining. The culture characteristics, including growth patterns on different media, pigmentation, colony color, presence, and color of aerial and substrate mycelium on various ISP media (ISP1 to ISP7), were determined.

Fermentation and Ethyl Acetate Extract Preparation {#S2.SS5}
--------------------------------------------------

International Streptomyces Project medium no. 2 (ISP2) (0.5 g of peptone, 0.3 g of malt extract, 0.3 g of yeast extract, and 1.0 g of dextrose pH 6.2 ± 0.2) was used as fermentation medium for the exploration of the secondary metabolites produced by the 42 mangrove Actinobacteria isolates. The ISP2 medium was sterilized by autoclave at 121°C at 15 lb for 20 min. Initially, about four to five colonies from pure culture were inoculated into modified ISP2 media supplemented with 2.0 g/l of calcium carbonate in an Erlenmeyer conical flask and incubated at 150 rpm at 28°C for 7 days. After the incubation period, 5% (v/v) of well-grown culture from the calcium carbonate-supplemented ISP2 medium was inoculated into ISP2 media in an Erlenmeyer conical flask. The flask was incubated at 150 rpm at 28°C for 14 days. The uninoculated ISP2 medium served as a medium control, to ensure purity. After fermentation, the spent medium of the isolates was centrifuged at 5,000 rpm for 10 min, and the culture supernatant was filtered through a 0.2 μm nitrocellulose filter. The cell-free extracts were stored at -20°C. For the extraction of secondary metabolites by ethyl acetate, the cell-free filtrate was extracted twice with an equal volume of ethyl acetate, and the organic extract was condensed by evaporating ethyl acetate using a rotational evaporator (Heidolph Laborata, 4001) ([@B6]). The organic extract was resuspended in ethyl acetate and was used for further studies.

Efficacy of Rare Marine Actinobacteria Cell-Free Extract Against *Vibrio cholerae* HYR14 Biofilm {#S2.SS6}
------------------------------------------------------------------------------------------------

The antibiofilm activity of various dilutions of the 42 RMA cell-free extracts (50, 25, 12.50, 6.25, and 3.13%) was investigated. One hundred microliters (final volume) of LB broth containing various concentrations of RMA cell-free extract was aliquoted into a 96-well microtiter plate. Ten microliters of an overnight-grown culture of *V. cholerae* HYR14 strain that has been diluted up to 1:100 (OD~595~ = 0.2) was inoculated into each well, and the plates were incubated at 37°C for 24 h. Controls were included for all the experiments. After the incubation period, the plates were subjected to crystal violet staining. The medium and the planktonic cells present in the 96-well microtiter plates were aspirated at the end of the incubation period. The non-adherent HYR14 cells present in the wells were discarded by washing the wells thrice with sterile 1× phosphate-buffered saline. The microtiter plates were then air-dried for 20 min at ambient temperature to fix the adherent biofilms. To the dried wells, 100 μl of 0.2% (w/v) crystal violet was added and incubated for 20 min at room temperature. After the incubation period, the excess stain was washed off with sterile water twice, and the plates were air-dried completely. The bound crystal violet was solubilized by pipetting 100 μl of 33% glacial acetic acid into each well ([@B26]). The absorbance of the wells was measured at 595 nm using an iMark^TM^ microplate absorbance reader (Bio-Rad Laboratories, Inc., United States).

Nucleic Acid-Based Identification of Rare Marine Actinobacteria Strain Demonstrating *Vibrio cholerae* Biofilm Inhibitory Activity {#S2.SS7}
----------------------------------------------------------------------------------------------------------------------------------

The extraction of the genomic DNA of the RMA strain exhibiting a significant inhibitory activity against the *V. cholerae* HYR14 biofilm was performed using commercially available DNeasy Blood and Tissue kits (Qiagen, Germany) as per the manufacturer-recommended protocol ([@B2]). Until further use, the eluted DNA was stored at -20°C. Nested PCR targeting the 16SrRNA of the eubacterial genome was done using primers: forward primer (U1): 5′-TTGGAGAGTTTGATCCTGGCTC-3′ and reverse primer U4: 5′-GGACTACCAGGGTATCTA-3′ for the first round of nested PCR and forward primer (U2): 5′-TTGGAGAGTTTGATCCTGGCTC-3′) and reverse primer (U3): 5′-GCGGCTGGCACGTAGTTAG-3′ for the second round of nested PCR ([@B51]). The reaction conditions were set as described in [@B27]. The amplified product was then cyclo-sequenced, purified, and loaded to ABI3200 genetic analyzer (Applied Biosystems, United States) and sequenced as described previously ([@B1]). The obtained sequence was analyzed using BioEdit software (version 7.0.5.3) and was compared with 16S rRNA sequence database of National Center for Biotechnology Information (NCBI) using nucleotide BLAST ([@B4]). The phylogenetic tree was constructed using the neighbor-joining method ([@B37]) and was validated using bootstrap analysis. The sequence was submitted to GenBank for accession number.

Quantification of Biofilm Formation and Eradication {#S2.SS8}
---------------------------------------------------

To evaluate the effect of RMA46 organic extract on mature *V. cholerae* biofilm, 100 μl of fresh LB broth was aliquoted into a 96-well microtiter plate. This was inoculated with 10 μl of an overnight-grown culture of *V. cholerae* HYR14 strain that had been diluted up to 1:100 (OD~595~ = 0.2). The microtiter plate was incubated at 37°C for 24 h. After the incubation period, the non-adherent planktonic cells were aspirated gently without disturbing the biofilm. To the wells, 100 μl (final volume) of LB broth containing various concentrations of RMA46 organic extract (50--0.13 mg/ml) was aliquoted. The microtiter plate was incubated again at 37°C for 24 h. Following the incubation period, crystal violet assay was performed to evaluate the potential of RMA46 organic extract on eradication of *V. cholerae* biofilm. Untreated and vehicle controls were also included for all experiments ([@B6]).

To quantify the effect of RMA46 organic extract on the formation of *V. cholerae* biofilm, 100 μl (final volume) of LB broth containing various concentrations of RMA46 organic extract (50--0.13 mg/ml) was aliquoted into 96-well microtiter plate. Ten microliters of an overnight-grown culture of *V. cholerae* HYR14 strain that has been diluted up to 1:100 (OD~595~ = 0.2) was inoculated into each well, and the plates were incubated at 37°C for 24 h. After the incubation period, the plates were subjected to crystal violet staining. Untreated and vehicle controls were also included for all experiments.

For crystal violet staining, the medium and the planktonic cells present in the 96-well microtiter plates were aspirated at the end of the incubation period. The non-adherent HYR14 cells present in the wells were discarded by washing the wells thrice with sterile 1 × phosphate-buffered saline. The microtiter plates were then air-dried for 20 min at ambient temperature to fix the adherent biofilms. To the dried wells, 100 μl of 0.2% (w/v) crystal violet was added and incubated for 20 min at room temperature. After the incubation period, the excess stain was washed off with sterile water twice, and the plates were air-dried completely. The bound crystal violet was solubilized by pipetting 100 μl of 33% glacial acetic acid into each well ([@B26]). The absorbance of the wells was measured at 595 nm using an iMark^TM^ microplate absorbance reader (Bio-Rad Laboratories, Inc., United States).

Confocal Laser Scanning Microscopic Analysis {#S2.SS9}
--------------------------------------------

*V. cholerae* HYR14 (OD~595~ = 0.1) and RMA46 ethyl acetate extract at a concentration of (9.3 mg/ml) were inoculated into LB medium in cell culture plate containing sterile borosilicate coverslips and were incubated statically at 37°C for 24 h. After 24 h, the suspension was aspirated and removed carefully. The biofilms established on the coverslips were rinsed with 0.9% NaCl solution. Stock solutions of SYTO^TM^ 9 green fluorescent stain (Thermo Fisher Scientific) and propidium iodide red fluorescent dyes (BacLight, Invitrogen Ltd.) were prepared at 1:1 ratio and stored at −20°C until further use. Briefly, 200 μl of the dyes was added to the coverslips and incubated at room temperature for 15 min under dark conditions. After incubation, the dyes were aspirated, and the coverslips were carefully washed with 0.9% NaCl. The washed coverslips were air-dried at ambient temperature and fixed on a sterile glass slide. These slides were observed under a 40× objective using a confocal laser scanning microscope (Olympus FLUOVIEW, FV1000). The biomass, average thickness, and roughness coefficient of biofilms were analyzed using COMSTAT package in MATLAB R2017b ([@B21]).

Cell Viability Assay {#S2.SS10}
--------------------

The effect of the RMA46 ethyl acetate extract on host cell viability was assayed using murine macrophages RAW264.7, cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 1% penicillin/streptomycin (w/v), and 1% [L]{.smallcaps}-glutamine using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. About 1 × 10^4^ RAW264.7 cells/well were seeded in a 96-well microtiter plate and incubated at 37°C in a CO~2~ incubator for 24 h. After the incubation period, the cells were treated with various concentrations (0.13, 0.39, and 9.375 mg/ml) of *Micromonospora* sp. RMA46 ethyl acetate extract and incubated for another 24 h at 37°C in a CO~2~ incubator. After 24 h, 1 mg/ml of MTT was added, and the microtiter plate was incubated at 37°C for 3 h. Dimethyl sulfoxide (DMSO) was added to dissolve the formazan crystals, and absorbance was read at 570 nm using a microplate reader spectrophotometer (Synergy H1) ([@B25]).

Extraction of RNA and Quantitative Analysis of Virulence Gene Expression in *Vibrio cholerae* HYR14 {#S2.SS11}
---------------------------------------------------------------------------------------------------

Total RNA was extracted from the RMA46 extract-treated and untreated *V. cholerae* HYR14 from stationary phase culture (24 h) using RNeasy^®^ Protect Bacteria Mini Kit (Qiagen), according to the manufacturer's guidelines. The purity and integrity of the isolated RNA were checked using NanoDrop (Thermo Fisher Scientific, United States). Preparation of cDNA was performed using the iScript^TM^ cDNA Synthesis kit with a concentration of 100 ng following the manufacturer's guidelines. The following conditions were set for cDNA synthesis; 24°C for 5 min (annealing), 42°C for 30 min (extension), and 85°C for 5 min (inactivation). The effect of RMA46 ethyl acetate extract on the virulence gene expression in the HYR14 strain was analyzed by qRT-PCR using primers listed in [Supplementary Table S4](#TS1){ref-type="supplementary-material"}. The 16s rRNA was used as the reference gene. The relative gene expression was calculated using the 2^--Δ^ ^Δ^ ^CT^ method ([@B54]; [@B20]).

Gas Chromatography--Mass Spectrometry Analysis {#S2.SS12}
----------------------------------------------

Separation and identification of the active compounds present in the ethyl acetate extract of RMA46 were performed with a PerkinElmer Clarus 500 GC-MS system. Helium was employed as a carrier gas at a flow rate of 1 ml/min, and the injector temperature was set at 280°C. The program of the column temperature was held at 50°C for 1 min and increased at 10°C/min to 150°C (1 min hold), to 250°C for 1 min hold, and then at 15°C/min to 300°C (3 min hold). The mass spectrometer was operated at a mass range of 40--450 amu. One microliter of RMA46 extract dissolved in ethyl acetate was injected into the system. The separated compounds were identified by comparing their spectra with those in the National Institute of Standards and Technology (NIST) mass spectral library ([@B41]).

Computational Studies {#S2.SS13}
---------------------

Two-dimensional structures of the compounds identified in the *Micromonospora* sp. RMA46 ethyl acetate were drawn using MarvinSketch^[1](#footnote1){ref-type="fn"}^. The ligands were prepared for molecular docking using LigPrep (Schrödinger, LLC, New York, NY, 2020). The primary structure of the ATP binding domain of LuxO (Q9KT84) was retrieved from Uniprot^[2](#footnote2){ref-type="fn"}^. Protein BLAST (BLASTp) was performed for the query sequence against Protein Data Bank (PDB) to identify the structurally similar homolog. The QS signal integrator LuxO of *Photobacterium angustum* with the PDB accession number 5EP0 was chosen as the template. Homology modeling was performed using the protein structure prediction tool implemented in BioLuminate (Schrödinger, LLC, New York, NY, 2020). The modeled protein was subjected to a constrained energy minimization using GROMACS ([@B28]), and the quality of the modeled structure was further evaluated using the SAVES server^[3](#footnote3){ref-type="fn"}^. The experimentally solved structure of HapR protein (2PBX) was downloaded and used for molecular docking simulations. Both the LuxO and HapR proteins were prepared using the protein preparation wizard ([@B46]). A grid box was generated and was centered on the binding sites of the target proteins, and the docking simulation was performed using extra precision (XP) docking algorithm implemented in Glide (Schrödinger, LLC, New York, NY, 2020) ([@B14]).

Statistical Analysis {#S2.SS14}
--------------------

GraphPad Prism software version 8.0.2 (GraphPad Software Inc., San Diego, CA, United States) was used for analyzing the data statistically. The significance was analyzed by Student *t*-test with *p* set at *p* ≤ 0.05. All the assays were performed in triplicates, and the results have been expressed as mean ± SD.

Results {#S3}
=======

Mangrove Soil Is Rich in Morphologically Distinct Rare Marine Actinobacteria {#S3.SS1}
----------------------------------------------------------------------------

Non-*Streptomyces* like colonies that were selectively subcultured for the isolation of pure RMAs produced a wide range of colonies from round convex to dry, raised, irregularly edged colonies. These colonies also produced varied colony pigments from white, yellow, pink, orange, brownish-orange, gray, and black. Out of the 42 isolates, only one isolate (RMA44) produced diffusible pigment. Light microscopy revealed that a variety of structures including coccus, rod-coccus, coryneform, and short- and long-branched sometimes filamented hyphal formations. Many of these hyphal-producing strains also formed oval spores. The pattern of hyphae and spore formation also varied significantly among RMA isolates. A few isolates changed colony pigmentation from orange to black as the colonies got older ([Supplementary Table S3](#TS1){ref-type="supplementary-material"}). This showed that the mangrove soil supported a rich diversity of Actinobacteria.

Mangrove-Derived Rare Marine Actinobacteria Extract Could Attenuate *Vibrio cholerae* HYR14 Biofilm {#S3.SS2}
---------------------------------------------------------------------------------------------------

The cell-free culture supernatants of all the 42 RMA isolates were screened for an anti-biofilm activity. The isolates RMA2, RMA4, RMA15, RMA42, RMA44, RMA45, RMA46, and RMA49 exhibited a \> 50% biofilm inhibitory activity ([Figure 1A](#F1){ref-type="fig"}). However, the cell-free culture supernatant of RMA46 exhibited a consistent level of ≥ 30% inhibition of HYR14 biofilm without a bactericidal activity at all concentrations (v/v) chosen in the study ([Figure 1B](#F1){ref-type="fig"} and [Supplementary Figure S1](#TS1){ref-type="supplementary-material"}). Therefore, the strain RMA46 was chosen for further investigations.

![**(A)** Effect of various concentrations of cell-free extract of 42 rare marine Actinobacteria (RMA) \[50, 25, 12.50, 6.25, and 3.13% (v/v)\] on 24 h biofilm of *Vibrio cholerae* HYR14. **(B)** Comparison of various concentrations \[50, 25, 12.50, 6.25, and 3.13% (v/v)\] of cell-free extracts of selected RMA strains that demonstrated significant HYR14 biofilm inhibitory activity. RMA46 displays the maximum (*p* \< 0.01) inhibition than do all the other strains. A one-sample *t*-test was used for significance analysis. \**p* \< 0.05, and \*\**p* \< 0.01.](fmicb-11-01393-g001){#F1}

Isolate RMA46 Belongs to the Genus *Micromonospora* {#S3.SS3}
---------------------------------------------------

The complete 16S rRNA sequence of the RMA46 strains (724 bp) determined in this study was deposited in GenBank database (accession number [MK788184.1](MK788184.1)). To study the evolutionary relationship, similarity search of 16S rRNA sequence of RMA46 was performed against 16S rRNA database in National Center for Biotechnology Information (NCBI). The closely related sequences of RMA46 were used to construct the phylogenetic tree. The result showed that the strain RMA46 is closely related to *Micromonospora* sp. 171111 (accession number [EF538723](EF538723)) and was clustered together in the phylogenetic tree ([Supplementary Figure S2](#TS1){ref-type="supplementary-material"}).

*Micromonospora* sp. RMA46 Ethyl Acetate Extract Effectively Inhibits Biofilm Formation by HYR14 Than by Eradicating Preformed Biofilms {#S3.SS4}
---------------------------------------------------------------------------------------------------------------------------------------

The RMA46 organic extract (50--0.13 mg/ml) was evaluated for its *Vibrio cholerae* HYR14 biofilm inhibitory/disruptive potential. The RMA46 ethyl acetate extract inhibited HYR14 biofilms ≥ 50% at low concentrations (0.39--0.13 mg/ml). At higher concentrations (0.59--50 mg/ml), the RMA46 ethyl acetate extract effectively inhibited \> 70% of the HYR14 biofilm formation ([Figure 2A](#F2){ref-type="fig"}). Overall, the data were consistent to show a dose-dependent increase in the inhibitory potential of RMA46 ethyl acetate extract against the *V. cholerae* HYR14 biofilm. On the contrary, the RMA46 ethyl acetate extract was unable to eradicate \> 50% of preformed biofilm ([Figure 2B](#F2){ref-type="fig"}). Because the biofilm inhibitory concentration (BIC) of RMA46 ethyl acetate extract ranges from 50 to 90%, three effective BICs were chosen -- BIC~50~ (0.13 mg/ml), BIC~60~ (0.39 mg/ml), and BIC~90~ (9.38 mg/ml) -- to validate anti-infective potential.

![**(A)** Dose-dependent inhibition of *Micromonospora* sp. RMA46 organic extract on the formation of *Vibrio cholerae* HYR14 biofilm. **(B)** Dose-dependent effect of RMA46 organic extract on preformed biofilm *V. cholerae* HYR14 biofilm. \* Effective concentrations chosen for further studies.](fmicb-11-01393-g002){#F2}

RMA46 Ethyl Acetate Extract Affects the Thickness and Biomass of *Vibrio cholerae* Biofilm {#S3.SS5}
------------------------------------------------------------------------------------------

Investigation on the effect of RMA46 ethyl acetate extract on HYR14 biofilm formation on coverslips was performed using confocal laser microscopy and COMSTAT analysis. Treatment with BIC~90~ (9.38 mg/ml) revealed a detached biofilm matrix, whereas the untreated control sample showed highly condensed and compact biofilms ([Figure 3A](#F3){ref-type="fig"}). COMSTAT analysis revealed that the untreated *V. cholerae* formed thicker biofilms (107.7 μm) with higher biomass (45.4 μm^3^/μm^2^) and a roughness coefficient of 0.27. Yet the RMA46 ethyl acetate treated HYR14 biofilms was 23.2 μm and 4.2 μm^3^/μm^2^ in thickness and biomass, respectively. The roughness coefficient of the RMA46 treated HYR14 biofilm is 1.30. These results signify that RMA46 ethyl acetate leads to an irregular distribution and reduced biomass of HYR14 than does the untreated HYR14 biofilm ([Figure 3B](#F3){ref-type="fig"}).

![**(A)** Confocal laser scanning microscopy of HYR14 biofilm in the presence of the RMA46 extract, visualized by red and green fluorescent vital dyes. **(B)** COMSTAT analysis on the biomass, average thickness, and roughness coefficient of HYR14 biofilm treated with RMA46 organic extract. Student's *t*-test was used for significance analyses. ^\*^*p* \< 0.05 was considered significant. \*\**p* \< 0.01, \*\*\**p* \< 0.001, and \*\*\*\**p* \< 0.0001.](fmicb-11-01393-g003){#F3}

RMA46 Ethyl Acetate Extract Does Not Affect Mammalian Cell Viability {#S3.SS6}
--------------------------------------------------------------------

The effect of ethyl acetate extract of RMA46 on the viability of host cells was assessed against macrophage RAW264.7 cell lines. Three concentrations, representing BIC~50~, BIC~60~, and BIC~90~ (0.13, 0.39, and 9.37 mg/ml, respectively), were chosen to investigate the extract's lethality for 24 h. In all treatments compared with the control (untreated macrophage RAW264.7 cells), the viability of the cells was not affected, which indicated the non-toxic nature of the extract without affecting the cell viability ([Figure 4](#F4){ref-type="fig"}).

![Dose-dependent effect of RMA46 ethyl acetate extract on the cell viability. Experiments were performed in triplicates, and difference in mean values was compared with that of the untreated experiment control. One-way ANOVA was used for multiple comparison analyses. ns denotes not significant.](fmicb-11-01393-g004){#F4}

RMA46 Extract Interferes With HYR14 Molecular Machinery {#S3.SS7}
-------------------------------------------------------

The real-time analysis of the expression pattern of *V. cholerae* HYR14 global switches (LuxO and HapR) and its downstream virulence genes -- *ct*, *tcp*, small regulatory RNAs (*qrr2* and *qrr4*), *aphA*, and *hapA* -- were quantified differentially under RMA46 organic (ethyl acetate) extract induced/uninduced state. At LSS, the global switch, LuxO is switched on to regulate the transcription of many other vital genes including the *tcp* and *ct* to encode toxin coregulated pilus and CTX, respectively. The small regulatory rRNA termed as *qrr*1-4 along with Hfq (RNA chaperone) binds with mRNA transcripts of *hap*R. HapR repression leads to the formation of biofilm. Similarly, at HSS, the de-repression of HapR leads to the suppression of biofilm formation and upregulation of protease production, causing dissemination of *V. cholerae*. In this regard, the expression analysis at BIC~50~ showed a 2--3 log~2~ fold reduction in the expression of LuxO and HapR and its downstream virulence genes *hapA*, *tcp*, and *ct*. Similarly, the treated (BIC~60~) cells showed a \> 2 log~2~ fold downregulation in the expression of the global regulators (LuxO and HapR) and virulence genes (*tcp* and *ct*). Overall, the data were significant to show that RMA46 extract interferes with the HYR14 molecular machinery in a dose-dependent manner to downregulate to \> 2--5 log~2~ fold, which confirmed that the entire virulence mechanism of *V. cholerae* has been switched off ([Figures 5A,B](#F5){ref-type="fig"}).

![Expression analysis of *Vibrio cholerae* virulence genes by quantitative PCR. **(A)** Heat map of real-time qRT-PCR to show the effect of RMA46 organic extract on virulence gene expression in *V. cholerae*. **(B)** Comparison between the various inhibitory concentration of RMA46 extract on HYR14 virulence-associated genes.](fmicb-11-01393-g005){#F5}

Metabolic Profiling of RMA46 and Their Molecular Interaction With Active Sites of LuxO and HapR {#S3.SS8}
-----------------------------------------------------------------------------------------------

With the use of gas chromatography--mass spectrometry (GC--MS), a total of 43 secondary metabolites were identified in the RMA46 extract belonging to different categories of secondary metabolites including alkanes (4.6%), alkenes (23.2%), carboxylic acids (25.5%), esters (6.9%), dairy ketone (4.6%), phenols (2.6%), and terpene (2.3%). The extract also contained aromatic monocyclic and heterocyclic compounds (20.9%) and other hydrocarbons (4.6%). Interestingly, the RMA46 extract also contained an oxaspiro compound (2.3%) ([Table 1](#T1){ref-type="table"} and [Supplementary Figure S3](#TS1){ref-type="supplementary-material"}).

###### 

List of compounds identified in *Micromonospora* sp. RMA46 ethyl acetate extract using GC--MS.

  **S. no.**   **Class of compound**              **Name of the compound**                                            **Molecular weight (g/mol)**   **Retention time (min)**   **Peak area (%)**
  ------------ ---------------------------------- ------------------------------------------------------------------- ------------------------------ -------------------------- -------------------
  1            Carboxylic acids                   2-Methoxy-propanoic acid                                            104                            4.26                       9.51
                                                  3-Methyl-butanoic acid                                              102                            5.60                       2.96
                                                  2-Methyl-butanoic acid                                              102                            5.74                       1.58
                                                  4-Methyl-3-pentenoic acid                                           114.14                         7.54                       0.19
                                                  α-Isopropylidene-aminooxy-propionic acid                            145.15                         9.11                       0.99
                                                  Benzoic acid                                                        122.12                         12.38                      0.90
                                                  Bis(2-methylpropyl)ester 1,2-benzenedicarboxylic acid               278.34                         31.11                      0.99
                                                  *N*-\[2-\[4-(Acetyloxy)-3-methoxyphenyl\]ethyl\]-acetamide          251                            33.78                      1.31
                                                  *N*-(3-Methylbutyl)acetamide                                        129.2                          10.73                      0.29
                                                  *N*-(2-Phenylethyl)acetamide                                        163                            21.88                      2.47
                                                  Bis(2-methylpropyl)ester 1,2-benzenedicarboxylic acid               278.34                         31.11                      0.99
  2            Alkenes                            1-Dodecene                                                          168.31                         11.05                      0.83
                                                  1-Tetradecene                                                       196                            15.19                      4.26
                                                  1*H*-Indene, 1-methylene-                                           128.17                         11.67                      0.68
                                                  1-Non-adecene                                                       266.5                          23.56                      7.66
                                                  Hexadecane                                                          266                            23.80                      0.56
                                                  (*E*)-5-Octadecene                                                  252.48                         29.30                      0.56
                                                  Cetene                                                              224.43                         29.45                      9.03
                                                  3- Methyl-, (*E*)-5-undecene                                        168                            15.51                      0.09
                                                  (*E*)-3-Eicosene                                                    280                            32.93                      7.02
                                                  1-Docosene                                                          308                            35.79                      5.53
  3            Alkanes                            Dodecane                                                            170.33                         11.18                      0.40
                                                  Tetradecane                                                         198                            15.35                      0.97
  4            Phenols                            2,4-Di-*tert*-butylphenol                                           206                            20.99                      0.95
                                                  2-Methoxy-4-vinylphenol                                             150.177                        14.31                      1.06
  5            Esters                             2-Phenylethyl ester acetic acid                                     164                            12.62                      0.12
                                                  Diphenyl ether                                                      170.2                          16.37                      0.04
                                                  2-Ethylhexyl salicylate                                             250                            30.07                      0.16
  6            Aromatic heterocyclic compounds    2-Coumaranone                                                       134                            12.76                      0.45
                                                  2,3-Dihydro-benzofuran                                              120                            13.32                      1.50
                                                  Biphenyl                                                            154                            15.92                      0.11
                                                  Hexahydro-pyrrolo\[1,2-*a*\]pyrazine-1,4-dione                      154.17                         31.36                      2.25
                                                  Hexahydro-3-(2-methylpropyl)-pyrrolo\[1,2-*a*\]pyrazine-1,4-dione   210                            33.44                      12.99
                                                  Hexahydro-3-(phenylmethyl)-pyrrolo\[1,2-*a*\]pyrazine-1,4-dione     244                            42.51                      3.15
  7            Heterocyclic hydrocarbon           4,5-Dimethyl-1,3-dioxane                                            116.16                         6.34                       0.11
  8            Terpene                            4-(1-Methylethyl)-2-cyclohexen-1-one                                138.20                         7.41                       0.03
  9            Aromatic hydrocarbon               1,4-Dichlorobenzene                                                 147                            8.11                       0.14
  10           Cyclic ketones                     3-Methyl-1,2-cyclopentanedione                                      112.13                         8.71                       0.15
  11           Aromatic monocyclic hydrocarbons   Phenylethyl alcohol                                                 122.16                         10.44                      0.32
                                                  Benzeneacetic acid                                                  136                            14.02                      11.58
                                                  Tetrahydro-4-hydroxy-6-pentyl-2*H*-pyran-2-one                      186.25                         20.68                      0.09
  12           Ketone                             Benzophenone                                                        182.22                         26.30                      0.58
  13           Oxaspiro compound                  7,9-Di-*tert*-butyl-1-oxaspiro(4,5)deca-6,9-diene-2, 8-dione        276.4                          32.17                      2.09

GC--MS, gas chromatography--mass spectrometry.

*QS global regulators*: LuxO and HapR drive the virulence mechanism including biofilm and CTX production in *V. cholerae* in response to low and high environmental signals. Because an experimentally solved structure of LuxO of *V. cholerae* is not available, we used a 1.6-Å resolution X-ray structure of the LuxO receiver-catalytic domain of *Photobacterium angustum*, which has 69% of sequence identity as a template for modeling *V. cholerae* LuxO ([Figure 6](#F6){ref-type="fig"}). Any gaps observed during core modeling were subjected to loop modeling using Schrödinger PRIME ([@B23]). Then, the modeled protein was subjected to a constrain-based energy minimization using GROMACS. The Ramachandran plot of the modeled protein showed that PHI and PSI angles of the modeled proteins are within the allowed ranges, and the modeled protein was acceptable and hence used for further docking studies. For HapR, an existing X-ray structure of 2.2-Å resolution with putative ligand-binding domains was used. The small molecules identified in the RMA46 ethyl acetate extract identified using GC--MS was docked with the active sites of LuxO and HapR ([Figure 7](#F7){ref-type="fig"}). Compound 2-methoxy-4-vinylphenol demonstrated an increased Glide score (-4.130) and Glide energy (-20.408 kcal/mol) with LuxO protein than did other molecules ([Figure 8](#F8){ref-type="fig"}). The interaction pattern was observed as the ligand forms hydrogen bonding with the most crucial amino acid residues (GLN363 and TYR139) of the receiver-catalytic domain of ATP binding domain of LuxO. Similarly, the ligand, hexahydro-3-(phenylmethyl)-pyrrolo\[1,2-*a*\]pyrazine-1,4-dione, was found to have the highest affinity with the HapR protein with a Glide score of -4.543 and Glide energy of -30.465 kcal/mol and formed hydrogen bond interaction with SER165 amino acid.

![Molecular superimposition of LuxO of *Photobacterium angustum* (template) and *V. cholerae*. The LuxO of *P. angustum* is represented in purple color and the LuxO of *V. cholerae* in turquoise color.](fmicb-11-01393-g006){#F6}

![**(A)** Docked complex of 2-methoxy-4-vinylphenol with LuxO of *Vibrio cholerae*, which forms hydrogen bond interaction with TYR129 and GLN363. **(B)** Interaction of hexahydro-3-(phenylmethyl)-pyrrolo\[1,2-*a*\]pyrazine-1,4-dione with HapR of *V. cholerae*, forming hydrogen bond with SER165. The *V. cholerae* response regulators are represented as surface (LuxO, gold color; and HapR, blue color), and the small molecules are represented as sticks.](fmicb-11-01393-g007){#F7}

![Docking scores of the bioactive compounds identified in the ethyl acetate extract of RMA46 with LuxO and HapR of *Vibrio cholerae*.](fmicb-11-01393-g008){#F8}

Discussion {#S4}
==========

The emergence of antimicrobial resistance among *Vibrio cholerae* is a burden on public health especially in developing countries ([@B12]). An increase in the incidence of multidrug resistance *V. cholerae* could hurt cholera-controlling measures within a community ([@B34]). To subdue the emergence of antibiotic resistance, natural compounds that exert anti-virulence properties have been recognized as an alternative strategy ([@B35]). Marine-derived Actinobacteria are a rich source of secondary metabolites that provide unique carbon scaffolds for the synthesis of advanced therapeutic agents for pathogens ([@B17]). More than 3,000 compounds have been reported from marine bacteria most prevalently from the phylum Actinobacteria, which are known to inhibit drug-resistant bacterial pathogens ([@B40]). The density of saprophytic Actinobacteria is high in mangrove soil owing to the detritus ecosystem found throughout the year ([@B44]). In this study, Actinobacteria strains were isolated from mangrove soil by various physical and chemical pretreatments by using a wide range of selective isolation media. It was observed that pretreatment of soil did not significantly affect the isolation of Actinobacteria strains. However, the application of starch casein agar and ISP no. 4 medium was most effective in the isolation of the Actinobacteria. The phylum Actinobacteria is one of the largest among the prokaryotes and encompasses many genera that are morphologically and phenotypically diverse.

The preliminary identification using light microscopy and colony morphology showed that the isolates were morphologically diverse, indicating the isolation of various genus. The isolated RMAs were screened using HYR14, a rugose *V. cholerae* O1 Ogawa biofilm-forming strain isolated during an outbreak in India. The strain is resistant to ampicillin, furazolidone, nalidixic acid, streptomycin, ciprofloxacin, erythromycin, and norfloxacin ([@B10]). Because the rugose phenomenon is stable even after passage into humans and their potential to cause epidemics, the multidrug-resistant HYR14 strain was chosen for the screening the RMAs that can inhibit biofilm formation by *V. cholerae* for the current study ([@B33]; [@B10]).

Although marine Actinobacteria account for 46% of the total Actinobacteria density exerting virulence inhibitory potential ([@B45]), the exploration for anti-virulence agents against *V. cholerae* had been very limited. Previously, culture supernatant of arctic derived rare Actinobacteria, *Nocardiopsis* sp. A731, had been reported to exhibit a biofilm inhibitory activity against *V. cholerae* ([@B5]). In our study, anti-biofilm phenotype-based screening of the RMA against HYR14 strain revealed that about 19% of the mangrove-derived isolates could inhibit the formation of *V. cholerae* biofilm. The study reinforces that the mangrove-derived Actinobacteria are a prospective source for anti-infectives against *V. cholerae*. Moreover, the HYR14 cell-free extract inhibits the formation of *V. cholerae* biofilms at a concentration (v/v) lesser than that of the *Nocardiopsis* sp. A731 reported by [@B5]. In the same study, 200 μg/ml of *Streptomyces* sp. A745 diethyl ether fraction has been reported to suppress 60% of *V. cholerae* biofilm. Yet in our study, about 50% inhibition was observed at 130 μg/ml of RMA46 ethyl acetate extract. Although eight RMA isolates showed a significant activity against HYR14 biofilms, only the RMA46 strain that showed \> 50% biofilm inhibition at least concentration was further subjected to nucleic acid-based identification. The sequence of the mangrove-derived *Micromonospora* sp. RMA46 was found to be closely related to the 16S rRNA sequence of another mangrove isolate *Micromonospora* sp. 171111. As both the strains were isolated from the mangrove region, the sequence similarity could reflect an environment selection among *Micromonospora* strains ([@B22]). The RMA46 ethyl acetate extract clearly eliminates the formation of HYR14 biofilm than its eradication. Previously, a non-significant impact on eliminating the preformed *V. cholerae* biofilms by natural products was attributed to their potential to affect the initial stages of biofilm formation including motility ([@B36]). Hence, further studies with the *V. cholerae* HYR14 are needed to understand the mechanism of inhibition of biofilm formation.

The signal (autoinducer) strength influences the QS global switches (LuxO and HapR) to enhance the survivability and persistence of the intestinal pathogen, *V. cholerae* ([@B24]). At LSS, LuxO is positively regulated, and its synergistic interaction with the global response regulator, TsrA, enhances the production of *Vibrio* polysaccharide (VPS) TCP and CT to establish biofilm and virulence ([@B58]).

When the signal strength is elevated (HSS), HapR is depressed, resulting in the upregulation of hemagglutinin/protease (HapA), facilitating the dispersal of *V. cholerae* cells within the biofilm matrix ([@B49]; [@B52]; [@B7]). Also, HSS is directly proportional to the increased population size of *Vibrio* in an environment, which might lead to nutrient depletion. Interestingly, under nutrient-limited condition, the expression of HapA protease increases owing to the elevated intracellular cAMP pool. The cAMP binds to its allosteric receptor and exerts a positive feedback loop to activate CRP, RpoS, and HapR ([@B7]). Our transcriptomic analysis revealed that the expression of major virulence genes and the response regulators of *V. cholerae* HYR14 is highly attenuated without affecting their growth in the presence of RMA46 ethyl acetate extract. This overall attenuation of the molecular machinery activated at LSS and HSS might be a combinatorial effect of two or more potential virulence attenuating bioactive molecules present in the RMA46 ethyl acetate extract against *V. cholerae*.

Genetically marine Actinobacteria are equipped to produce about 20 secondary metabolites ([@B29]). In this study, 43 secondary metabolites from various classes of chemical compounds have been identified. The RMA46 extract encompasses many chemicals from the class of carboxylic acid, and interestingly our group had previously reported the QS inhibitory effect of synthetically derived pyrazine-2-carboxylic acid on *V. cholerae* ([@B20]). The derivative of various other compounds reported in RMA46 has been reported to have other biological activities including antibacterial and anti-virulence activities against various other pathogens. This eventually exemplifies the potential of *Micromonospora* sp. RMA46 as a source for chemical structural templates for the development of anti-virulence agents. Docking of the 43 chemical compounds leads to the identification of 2-methoxy-4-vinylphenol and hexahydro-3-(phenylmethyl)-pyrrolo\[1,2-*a*\]pyrazine-1,4-dione to have the highest interacting capability with LuxO and HapR, respectively. The data corroborate our qRT-PCR data, which were also significant to show a complete blockage of virulence so as to prevent the colonization and dissemination of bacteria to persist infection. A derivative of 2-methoxy-4-vinylphenol has already been reported to have an inhibitory activity against LasIR/RhIIR circuit of *Pseudomonas aeruginosa* ([@B47]). Interestingly, hexahydro-3-(phenylmethyl)-pyrrolo\[1,2-*a*\]pyrazine-1,4-dione, also known as cyclo [D]{.smallcaps}-phenyalanyl-[L]{.smallcaps}-prolyl \[Cyclo(Phe-Pro)\], has been reported to attenuate the expression of genes associated with virulence in *V. cholerae*. Cyclo(Phe-Pro) inhibits the production of CTX and toxin coregulated pili in O1 El Tor strain by negatively affecting the transcription of genes *tcp*PH in *V. cholerae* ([@B9]). It was later shown that Cyclo(Phe-Pro) enhanced the ToxR-dependent transcription of *leu*O, which in turn repressed the downregulation of the ToxR regulon, altering the production of CT and TCP ([@B8]). However, the outcomes derived from this research support the bioprospecting of mangrove-derived *RMA* as sources of potential anti-infectives.

Conclusion {#S5}
==========

The pathogenesis of *Vibrio cholerae* is controlled via the QS-mediated communication process. The present study provides an insight in to the bioprospecting of mangrove-derived RMA to block QS-mediated response in *V. cholerae*. *Micromonospora* is one of the most productive genera among the phylum Actinobacteria in terms of the production of bioactive compounds. Yet the study of anti-virulence compounds with this genus is very limited. The Indian Ocean encompasses an astonishing source of marine microbial wealth, providing an opportunity to extensively exploit the RMA for the development of anti-virulence agents. The tapping of effective compounds from RMAs is achievable with the rapid development of modern technology in the field of sampling, isolation, and identification strategies that open up novel mechanisms to arrest the development of rapid dissemination of antimicrobial resistance and pathogenesis of human and animal pathogens. To conclude, the identification of the anti-virulence property of *Micromonospora* sp. is another example of Actinobacteria as a treasure trove for pharmaceutically important compounds.
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